292 related articles for article (PubMed ID: 26382552)
1. Novel directions in inflammation as a therapeutic target in atherosclerosis.
Verweij SL; van der Valk FM; Stroes ES
Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-inflammatory strategies in atherosclerosis.
van der Valk FM; van Wijk DF; Stroes ES
Curr Opin Lipidol; 2012 Dec; 23(6):532-9. PubMed ID: 23160400
[TBL] [Abstract][Full Text] [Related]
3. Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.
Zarzycka B; Nicolaes GA; Lutgens E
Expert Rev Clin Pharmacol; 2015 May; 8(3):297-313. PubMed ID: 25843158
[TBL] [Abstract][Full Text] [Related]
4. Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
Mendel I; Yacov N; Harats D; Breitbart E
Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734
[TBL] [Abstract][Full Text] [Related]
5. Targeting the immune response in atherosclerosis: It's time for clinical trials!
Joffre J; Ait-Oufella H
Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
[No Abstract] [Full Text] [Related]
6. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease.
Roman YM; Hernandez AV; White CM
Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory drugs and atherosclerosis.
Moubayed SP; Heinonen TM; Tardif JC
Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.
Yamashita T; Sasaki N; Kasahara K; Hirata K
J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783
[TBL] [Abstract][Full Text] [Related]
9. 2016 Jeffrey M. Hoeg Award Lecture.
Rouwet E; Lutgens E
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
[TBL] [Abstract][Full Text] [Related]
10. Emerging anti-inflammatory therapies for atherosclerosis.
Roubille F; Kritikou EA; Roubille C; Tardif JC
Curr Pharm Des; 2013; 19(33):5840-9. PubMed ID: 23438958
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
Maranhão RC; Leite AC
Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
[TBL] [Abstract][Full Text] [Related]
12. Recent advances on CD4
Grönberg C; Nilsson J; Wigren M
Eur J Pharmacol; 2017 Dec; 816():58-66. PubMed ID: 28457923
[TBL] [Abstract][Full Text] [Related]
13. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis.
Neele AE; Van den Bossche J; Hoeksema MA; de Winther MP
Eur J Pharmacol; 2015 Sep; 763(Pt A):79-89. PubMed ID: 26004034
[TBL] [Abstract][Full Text] [Related]
15. Targeting inflammation in cardiovascular diseases. still a neglected field?
Gómez-Guerrero C; Mallavia B; Egido J
Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.
Deroissart J; Porsch F; Koller T; Binder CJ
Handb Exp Pharmacol; 2022; 270():359-404. PubMed ID: 34251531
[TBL] [Abstract][Full Text] [Related]
17. Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis.
Li B; Li W; Li X; Zhou H
Curr Pharm Des; 2017; 23(8):1216-1227. PubMed ID: 28034355
[TBL] [Abstract][Full Text] [Related]
18. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
Taleb S; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
[TBL] [Abstract][Full Text] [Related]
19. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.
Little PJ; Chait A; Bobik A
Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977
[TBL] [Abstract][Full Text] [Related]
20. The monocyte/macrophage as a therapeutic target in atherosclerosis.
Saha P; Modarai B; Humphries J; Mattock K; Waltham M; Burnand KG; Smith A
Curr Opin Pharmacol; 2009 Apr; 9(2):109-18. PubMed ID: 19230773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
